NEVE ILAN, Israel, May 01, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its ...

By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it is collaborating with medical device distributor Adriamed to deploy ...

NEVE ILAN, Israel, Jan. 20, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today three senior level ...

Nanox has secured a long-awaited clearance from the FDA for its multi-source X-ray bed, designed to operate as a smaller, lighter imaging system in clinics and hospitals. The Nanox.ARC can employ up ...

The FDA gave clearance for Nanox's flagship 3D X-ray imaging device -- a huge development. The company still has to execute on the rest of its plan, and management expects that it will need to raise ...

Collaboration with Adriamed drives commercial expansion and strengthens Nanox’s regional leadershipEngagement supports continued growth across ...

Platform offers first of its kind service based on a 300+ radiologist network and over 20 FDA 510(k)-cleared artificial intelligence algorithms to support medical diagnostic industry The program is ...

Nanox has had a blockbuster year so far: After snagging FDA clearance in the spring for its single-source digital X-ray bed and making plans to begin the machine’s commercial rollout by the end of ...

Generated $3.0 million in revenue in the third quarter of 2024, compared to $2.5 million in the third quarter of 2023. Continued to expand the US sales and support teams, and made progress in ...

X-rays are taken for granted in the western world, but the World Health Organization believes that close to two-thirds of the global population do not have reliable access to diagnostic imaging. The ...

– According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average – Findings ...

Investors are growing impatient waiting for FDA approval of Nanox's primary device. There are also concerns over the leadership team and early insiders. The company is gaining potential applications, ...